| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 04/03/2002 | EP1192152A1 Novel fluorinated imidazoline benzodioxane, preparation and therapeutic uses thereof |
| 04/03/2002 | EP1192147A1 Mycolactone and related compounds, compositions and methods of use |
| 04/03/2002 | EP1191975A2 Improvement of t cell mediated immunity |
| 04/03/2002 | EP1191944A2 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES |
| 04/03/2002 | EP1191942A2 Treatment of endometriosis with antileukoprotease |
| 04/03/2002 | EP1191939A1 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone |
| 04/03/2002 | EP1191933A1 Nasal delivery of apomorphine |
| 04/03/2002 | EP1191931A1 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines as inhibitors of cyclooxygenase-2 |
| 04/03/2002 | EP1191928A1 Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women |
| 04/03/2002 | EP0988312B1 17beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis |
| 04/03/2002 | CN1342653A 1,6-fructostrontium biphosphate compounds and their preparing process and medical application |
| 04/03/2002 | CN1342482A Chinese patent medicine for treating nenoxenia |
| 04/03/2002 | CN1342470A Medicine for eliminating bursa |
| 04/03/2002 | CN1342457A Method for preventing vomit and sexual disorder using tetrahydrobenzo [cd] indole-6-formylamine compound |
| 04/02/2002 | US6365775 Biphenyl compounds and their use as oestrogenic agents |
| 04/02/2002 | US6365716 Binds to epitope of polypeptide having defined amino acid sequence; antitumor agents |
| 04/02/2002 | US6365715 Human cardiac/brain tolloid-like protein |
| 04/02/2002 | US6365609 Substituted 3,3-diamino-2-propenenitriles, their preparation and use |
| 04/02/2002 | US6365598 Pyrroloquinolines for treatment of obesity |
| 04/02/2002 | US6365582 S-substitute 11β-benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds |
| 04/02/2002 | US6365402 Growth differentiation factor-9 |
| 04/02/2002 | US6365371 Amino acid sequence; diagnosis, prevention and treatment of cancer, reproductive disorders, immune disorders, and developmental disorders; anticarcinogenic agents |
| 04/02/2002 | US6365370 Dna which codes for 5-hydroxytryptamine 3-c protein of defined amino acid sequence; antiinflammatory agents; treatment of huntington's disease, alzheimer's disease and others |
| 04/02/2002 | US6365164 Injecting therapeutic amount of botulinum toxin into prostate gland of patient, thereby alleviating symptoms of prostatic hyperplasia, benign prostatic hyperplasia or prostatic enlargement |
| 04/02/2002 | US6365159 Spo-rel |
| 04/02/2002 | CA2144047C Method and compositions for maintaining glomerular filtration rate while inhibiting extracellular matrix accumulation |
| 03/29/2002 | WO2003045398A1 Methods of making and pharmaceutical formulations comprising 7alpha, 11beta-dimethy-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof |
| 03/28/2002 | WO2002024924A2 Protein phosphatases |
| 03/28/2002 | WO2002024910A2 Isolated human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 03/28/2002 | WO2002024891A2 B7-like molecules and uses thereof |
| 03/28/2002 | WO2002024726A2 Olfactory and pheromones g-protein coupled receptors |
| 03/28/2002 | WO2002024703A1 Bicyclic heteroaromatic compounds |
| 03/28/2002 | WO2002024702A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/28/2002 | WO2002024698A1 Xanthine phosphodiesterase v inhibitors |
| 03/28/2002 | WO2002024694A1 Pyrazolopyridines and pyrazolopyridazines as antidiabetics |
| 03/28/2002 | WO2002024683A1 Farnesyl transferase inhibiting 6-[(substituted phenyl)methyl]-quinoline and quinazoline derivatives |
| 03/28/2002 | WO2002024681A2 Pyrazine derivatives as modulators of tyrosine kinases |
| 03/28/2002 | WO2002024662A1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 03/28/2002 | WO2002024661A2 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 03/28/2002 | WO2002024653A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | WO2002024639A1 Cyclopentane derivatives as therapeutic agents |
| 03/28/2002 | WO2002024222A2 Ligands for g protein coupled receptors and methods of using them |
| 03/28/2002 | WO2002024221A2 Notch receptor agonists and uses |
| 03/28/2002 | WO2001090144A3 Vip-related peptides for the treatment of sexual disorders in women |
| 03/28/2002 | WO2001090106A3 Tryasolyl tropane derivatives as ccr5 modulators |
| 03/28/2002 | WO2001055356A3 Human protein kinases and protein kinase-like enzymes |
| 03/28/2002 | WO2001051642A3 Dna modification proteins |
| 03/28/2002 | WO2001038486A3 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 03/28/2002 | WO2001032702B1 Molecular structure of rhd negative locus |
| 03/28/2002 | US20020037911 Arylthiazolidinedione derivatives |
| 03/28/2002 | US20020037892 Bis-arylsulfones |
| 03/28/2002 | US20020037862 Muscle relaxants; sexual disorders |
| 03/28/2002 | US20020037850 Genetic engineering; binding to antibodies |
| 03/28/2002 | US20020037828 Pretreatment sexual intercourse |
| 03/28/2002 | US20020037524 Nucleotide sequences for use in diagnosis, treatment and prevention of cancer, inflammation, autoimmune disease and infections |
| 03/28/2002 | US20020037491 Oral transmucosal delivery |
| 03/28/2002 | US20020037287 For diagnosis and therapy of myeloma and ovarian cancer |
| 03/28/2002 | DE10043321A1 Transdermales therapeutisches System Transdermal therapeutic system |
| 03/28/2002 | DE10028376A1 Epididymis-spezifische Proteine mit Fibronektin Typ II-Modulen Epididymis-specific proteins with fibronectin type II modules |
| 03/28/2002 | CA2433157A1 Cyclopentane derivatives as therapeutic agents |
| 03/28/2002 | CA2423106A1 Compounds and methods for modulation of estrogen receptors |
| 03/28/2002 | CA2423104A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/28/2002 | CA2423071A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/28/2002 | CA2423050A1 Pyrazine derivatives as modulators of tyrosine kinases |
| 03/28/2002 | CA2422215A1 B7-like molecules and uses thereof |
| 03/28/2002 | CA2421865A1 Olfactory and pheromones g-protein coupled receptors |
| 03/28/2002 | CA2420862A1 Protein phosphatases |
| 03/27/2002 | EP1191036A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 03/27/2002 | EP1191035A2 Three members of the cytokin-receptor class II family |
| 03/27/2002 | EP1190086A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies |
| 03/27/2002 | EP1190072A2 22012, a novel human carboxypeptidase |
| 03/27/2002 | EP1190071A2 17867, a novel human aminopeptidase |
| 03/27/2002 | EP1190059A1 Sgip peptides |
| 03/27/2002 | EP1190055A2 Human endogenous retrovirus in breast cancer |
| 03/27/2002 | EP1190051A2 Human transport proteins |
| 03/27/2002 | EP1189942A1 Somatostatin agonists |
| 03/27/2002 | EP1189941A1 Neuromedin b and somatostatin receptor agonists |
| 03/27/2002 | EP1189907A1 Thienopyrimidines as phosphodiesterase inhibitors |
| 03/27/2002 | EP1189905A1 Substituted heterocycle fused gamma-carbolines |
| 03/27/2002 | EP1189904A1 Substituted heterocycle fused gamma-carbolines |
| 03/27/2002 | EP1189630A1 A method of prophylaxis and treatment and agents useful for same |
| 03/27/2002 | EP1189620A1 Formulation comprising testosteron undecanoate and castor oil |
| 03/27/2002 | EP1189619A1 Administration of non-oral androgenic steroids to women |
| 03/27/2002 | EP1189605A2 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof |
| 03/27/2002 | EP1189583A1 Indole derivatives |
| 03/27/2002 | EP1064284B1 Hypnotic beta-carboline derivatives, process for their preparation and their use as medicinal products |
| 03/27/2002 | EP1007534A4 Bh3 interacting domain death agonist |
| 03/27/2002 | EP0873336B1 Antagonists of gonadotropin releasing hormone |
| 03/27/2002 | EP0734255B1 Novel potassium channel agonist produced from trichoderma virens |
| 03/27/2002 | CN1342163A Ketolide antibiotics |
| 03/27/2002 | CN1342077A Inhibition of formation of vascular hyperpermeability |
| 03/27/2002 | CN1341440A Male wingless cockroach yang-strengthening liquor |
| 03/27/2002 | CN1341428A Chinese medicine for curing VD |
| 03/27/2002 | CN1081638C Thienopyrimidines |
| 03/27/2002 | CN1081460C Use of medicine for reducing tissue damage associated with non-cardiac ischemia by aldose reductase inhibitor |
| 03/26/2002 | US6362371 β2- adrenergic receptor agonists |
| 03/26/2002 | US6362324 Used as target for diagnosis and treatment in aminopeptidase-related disorders such as aging, cancers, cataracts, cystic fibrosis and leukemias; used in drug-screening to identify agonists, antagonists |
| 03/26/2002 | US6362237 Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception |
| 03/26/2002 | US6362222 Topical applying |
| 03/26/2002 | US6362190 Administering compounds such as 3-(2-phenylethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene -carboxamidomethylpyridi nyl)-2-pyrazinone, n'-((1-(aminoiminomethyl)4-piperidinyl) methyl)-n-(3,3-diphenylpropionyl)-l-proline amide |